Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizio Armeni

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Pharmacoeconomics|January 20, 2023
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in ItalyCarla Rognoni, Camilla Falivena, Francesco Costa, et al.
Advances in Therapy|February 8, 2024
Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in ItalyCarla Rognoni, Domenica Lorusso, Francesco Costa, et al.
Clinical Therapeutics|January 22, 2020
Cost-benefit Analysis in Health Care: The Case of Bariatric Surgery Compared With DietCarla Rognoni, Patrizio Armeni, Rosanna Tarricone, et al.
Health Policy (Amsterdam, Netherlands)|December 16, 2025
The relationship between trust and compliance in the Italian NHS: Results of the People's Voice SurveyRosanna Tarricone, Patrizio Armeni, Catherine Arsenault, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Claudio Jommi, Patrizio Armeni, Arianna Bertolani, et al.
Clinical Therapeutics|December 29, 2019
Implementation of Value-based Pricing for MedicinesClaudio Jommi, Patrizio Armeni, Francesco Costa, et al.
Social Science & Medicine (1982)|December 26, 2016
The impact of HTA and procurement practices on the selection and prices of medical devicesGiuditta Callea, Patrizio Armeni, Marta Marsilio, et al.
International Journal of Environmental Research and Public Health|February 3, 2021
Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A ProposalPatrizio Armeni, Marianna Cavazza, Entela Xoxi, et al.
Plos One|May 20, 2022
The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysisLudovica Borsoi, Patrizio Armeni, Gleb Donin, et al.
International Journal of Technology Assessment in Health Care|April 13, 2026
Implementing the EU HTA regulation and joint clinical assessment: a multi-stakeholder perspective from ItalyMichela Meregaglia, Francesco Costa, Ludovico Cavallaro, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Pharmacoeconomics|January 20, 2023
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in ItalyCarla Rognoni, Camilla Falivena, Francesco Costa, et al.
Advances in Therapy|February 8, 2024
Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in ItalyCarla Rognoni, Domenica Lorusso, Francesco Costa, et al.
Clinical Therapeutics|January 22, 2020
Cost-benefit Analysis in Health Care: The Case of Bariatric Surgery Compared With DietCarla Rognoni, Patrizio Armeni, Rosanna Tarricone, et al.
Health Policy (Amsterdam, Netherlands)|December 16, 2025
The relationship between trust and compliance in the Italian NHS: Results of the People's Voice SurveyRosanna Tarricone, Patrizio Armeni, Catherine Arsenault, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Claudio Jommi, Patrizio Armeni, Arianna Bertolani, et al.
Clinical Therapeutics|December 29, 2019
Implementation of Value-based Pricing for MedicinesClaudio Jommi, Patrizio Armeni, Francesco Costa, et al.
Social Science & Medicine (1982)|December 26, 2016
The impact of HTA and procurement practices on the selection and prices of medical devicesGiuditta Callea, Patrizio Armeni, Marta Marsilio, et al.
International Journal of Environmental Research and Public Health|February 3, 2021
Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A ProposalPatrizio Armeni, Marianna Cavazza, Entela Xoxi, et al.
Plos One|May 20, 2022
The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysisLudovica Borsoi, Patrizio Armeni, Gleb Donin, et al.
International Journal of Technology Assessment in Health Care|April 13, 2026
Implementing the EU HTA regulation and joint clinical assessment: a multi-stakeholder perspective from ItalyMichela Meregaglia, Francesco Costa, Ludovico Cavallaro, et al.
Pageof 5